Symbol="NBRV"
AssetType="Common Stock"
Name="Nabriva Therapeutics AG"
Description="Nabriva Therapeutics plc, a biopharmaceutical company, is dedicated to the development and commercialization of new anti-infective agents to treat serious infections. The company is headquartered in Dublin, Ireland."
CIK="1641640"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="56 FITZWILLIAM SQUARE, DUBLIN, IE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4546100"
EBITDA="-46847000"
PERatio="None"
PEGRatio="-0.06"
BookValue="-1.361"
DividendPerShare="0"
DividendYield="0"
EPS="-19.67"
RevenuePerShareTTM="12.61"
ProfitMargin="-1.481"
OperatingMarginTTM="-1.288"
ReturnOnAssetsTTM="-0.652"
ReturnOnEquityTTM="-2.685"
RevenueTTM="36505000"
GrossProfitTTM="-10226000"
DilutedEPSTTM="-19.67"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.054"
AnalystTargetPrice="1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.166"
PriceToBookRatio="0.239"
EVToRevenue="0.0009"
EVToEBITDA="0.0523"
Beta="1.555"
num_52WeekHigh="8.45"
num_52WeekLow="0.425"
num_50DayMovingAverage="1.416"
num_200DayMovingAverage="1.689"
SharesOutstanding="3201500"
DividendDate="2020-12-03"
ExDividendDate="None"
symbol="NBRV"
open="0.60"
high="0.80"
low="0.60"
price="0.80"
volume="6032.00"
latest_trading_day="2023-08-11"
previous_close="0.82"
change="-0.03"
change_percent="-3.4788%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="74"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="26"
Volume_recent_avg="19882"
Change_recent_avg="0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="1.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="26"
Aroon_momentum_negative="74"
image_negative_thumbnail_id_1="516"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_negative_thumbnail_id_2="1157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="522"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_positive_thumbnail_id_1="1006"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_positive_thumbnail_id_2="967"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0129.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
